| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
BIBERACH, Germany—To prepare potential drug compounds for HTS, one of the most time consuming but critical steps is accurately weighing out samples. This is a straightforward process for dry powders, but sample sticking and loss is very problematic with oils, tars, and gums. To address this problem, researchers at Boehringer Ingelheim Pharma designed the compounds in vials dissolution station (CIVDISS).
 
In a poster presented at the recent SBS conference in Montreal, the researchers explained that they avoided weighing issues by adding DMSO to the master vial to achieve the desired concentration. They then replaced the traditional mixing device, which they suggest offers poor reproducibility and long timelines, with a focused acoustic mixing device. Because the acoustic mixer relies on a water bath, the researchers recapped the master vials before mixing to prevent water contamination.
 
Upon removing the desired quantity of sample for plating, they logged this amount into the inventory system and either stored the remaining sample or freeze dried it to prevent long-term degradation. According to the researchers, the turnaround time to process 96 samples into triplicate plates is about five hours.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue